학술논문

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Document Type
Article
Source
In: Neurology. (Neurology, 26 October 2010, 75(17):1560-1566)
Subject
Language
English
ISSN
00283878
1526632X